P15.01: Risk assessment of pre-eclampsia according to FMF model in local practice
نویسندگان
چکیده
منابع مشابه
[Pre-eclampsia treatment according to scientific evidence].
Hypertensive disorders in pregnancy deserve special attention in the setting of global public health. Currently, they represent the third cause of maternal mortality in the world and first in Brazil. From a practical standpoint, pre-eclampsia remains a syndrome that leads to serious repercussions on maternal and fetal mortality and its etiology is not well known. Currently, the best treatment f...
متن کاملCardiovascular risk factor assessment after pre-eclampsia in primary care
BACKGROUND Pre-eclampsia is associated with an increased risk of development of cardiovascular disease later in life. It is not known how general practitioners in the Netherlands care for these women after delivery with respect to cardiovascular risk factor management. METHODS Review of medical records of 1196 women in four primary health care centres, who were registered from January 2000 un...
متن کاملAssessment of Correlation Between miR-210 Expression and Pre-Eclampsia Risk: A Meta-Analysis
Background: Pre-eclampsia (PE) is a pregnancy disorder characterized by hypertension and proteinuria. The evidence has suggested that microRNAs (miRs) are associated with pre-eclampsia pathogenesis; however, these results are inconsistent. The aim of this study was to assess the association between miR-210 expression and PE risk. Methods: Previous studies were selected using PubMed, Scopus, ...
متن کاملEconomic assessment of screening for pre-eclampsia.
BACKGROUND Pre-eclampsia is a major contributor to maternal and neonatal morbidity and mortality. Our objectives in this study are to economically assess, from the payer perspective, routine screening for pre-eclampsia using placental markers -placental protein 13 and placental growth factor - and uterine artery Doppler compared with standard care. METHODS A decision model was developed, whic...
متن کاملBest evidence in anesthetic practice: prevention: magnesium sulfate reduces the risk of eclampsia in women with pre-eclampsia.
Structured abstract Question: In women with pre-eclampsia, does peripartum administration of magnesium sulfate decrease the risk of eclampsia, maternal morbidity, or neonatal morbidity compared to placebo? Design: Multicentre, randomized, double-blind, placebo-controlled trial. Setting: One hundred and seventy-five secondary and tertiary level hospitals in 33 countries. Patients: Ten thousand o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ultrasound in Obstetrics & Gynecology
سال: 2018
ISSN: 0960-7692
DOI: 10.1002/uog.19732